🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

116 results for “PRECISION” Clear

  1. Part A: 20 and 40 mg PRAX-944

    PRECISION BIOSCIENCES INC

    Essential Tremor

    phase 2 small molecule completed

    1 trial

  2. delolimogene mupadenorepvec

    PRECISION BIOSCIENCES INC

    Malignant Melanoma

    phase 2 gene therapy completed

    1 trial

  3. donor-derived NK cell infusion

    PRECISION BIOSCIENCES INC

    Non-small Cell Lung Cancer

    phase 2 mab active

    1 trial

  4. pCAR-19B cells

    PRECISION BIOSCIENCES INC

    Acute Lymphoblastic Leukemia

    phase 2 mab active

    2 trials

  5. A first in human study of people with chronic hepatitis B, where all participants will receive the new drug PBGENE-HBV. This study will use increasing dose amounts of the drug to see how safe and bearable it is. The study will also test how well PBGENE-HBV works and how it is processed by the body.

    PRECISION BIOSCIENCES INC

    Chronic Hepatitis B

    phase 1 other active

    1 trial

  6. Anti-CD123 CAR NK cells

    PRECISION BIOSCIENCES INC

    AML (Acute Myeloid Leukemia)

    phase 1 small molecule active

    1 trial

  7. Anti-CD19 UCAR-T cells

    PRECISION BIOSCIENCES INC

    Dermatomyositis, Juvenile

    phase 1 small molecule active

    1 trial

  8. Anti-CD5 CAR NK cells

    PRECISION BIOSCIENCES INC

    T-ALL/Lymphoma

    phase 1 mab active

    1 trial

  9. BCMA/CD70 CAR-T cells

    PRECISION BIOSCIENCES INC

    Systemic Lupus Erythematosus

    phase 1 mab active

    1 trial

  10. BCMA/CD70-targetd CAR-T

    PRECISION BIOSCIENCES INC

    Juvenile Dermatomyositis (JDM)

    phase 1 mab active

    1 trial

  11. BGM-2121

    PRECISION BIOSCIENCES INC

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  12. C-4-29 Cells

    PRECISION BIOSCIENCES INC

    Multiple Myeloma in Relapse

    phase 1 mab active

    1 trial

  13. CAR-T cells

    PRECISION BIOSCIENCES INC

    Relapsed Non-Hodgkin Lymphoma

    phase 1 mab active

    1 trial

  14. CD19 CAR-T cells

    PRECISION BIOSCIENCES INC

    Systemic Lupus Erythematosus

    phase 1 mab active

    1 trial

  15. CD19 targeted CAR-T cells

    PRECISION BIOSCIENCES INC

    SLE (Systemic Lupus)

    phase 1 mab active

    1 trial

  16. CD19-targetd CAR-T

    PRECISION BIOSCIENCES INC

    Juvenile Dermatomyositis

    phase 1 mab active

    1 trial

  17. CD70 CAR-T cells

    PRECISION BIOSCIENCES INC

    Ovarian Cancer

    phase 1 mab active

    1 trial

  18. CD70 CAR-T cells

    PRECISION BIOSCIENCES INC

    Renal Cell Carcinoma

    phase 1 mab active

    1 trial

  19. CD70 CAR-T cells

    PRECISION BIOSCIENCES INC

    Metastatic Tumor

    phase 1 mab active

    4 trials

  20. CD70-targeted CAR-T cells

    PRECISION BIOSCIENCES INC

    Renal Cell Carcinoma (RCC)

    phase 1 mab active

    1 trial

  21. CEA CAR-T cells

    PRECISION BIOSCIENCES INC

    Colorectal Cancer

    phase 1 mab active

    1 trial

  22. CEA CAR-T cells

    PRECISION BIOSCIENCES INC

    Gastric Cancer

    phase 1 mab active

    1 trial

  23. CEA-targeted CAR-T (Intravenous)

    PRECISION BIOSCIENCES INC

    NSCLC (Advanced Non-small Cell Lung Cancer)

    phase 1 mab active

    1 trial

  24. CEA-targeted CAR-T cells

    PRECISION BIOSCIENCES INC

    Peritoneal Metastases From Colorectal Cancer

    phase 1 mab active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources